Results 201 to 210 of about 2,242,189 (260)

Correction to: High expression of autophagy-related gene <i>EIF4EBP1</i> could promote tamoxifen resistance and predict poor prognosis in breast cancer. [PDF]

World J Clin Cases
Yang S, Hui TL, Wang HQ, Zhang X, Mi YZ, Cheng M, Gao W, Geng CZ, Li SN.   +8 more
europepmc   +1 more source

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα. [PDF]

J Exp Clin Cancer Res
Zhuang T, Zhang S, Liu D, Li Z, Li X, Li J, Yang P, Zhang C, Cui J, Fu M, Shen F, Yuan L, Zhang Z, Su P, Zhu J, Yang H.   +15 more
europepmc   +1 more source

miR-205 Regulates Tamoxifen Resistance by Targeting Estrogen Receptor Coactivator MED1 in Human Breast Cancer. [PDF]

Cancers (Basel)
Ouyang B, Bi M, Jadhao M, Bick G, Zhang X.   +4 more
europepmc   +1 more source

Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells. [PDF]

Biosci Rep
Gaballah AI, Elsherbiny AA, Sharaky M, Hamed NO, Raslan NA, Almilaibary A, Fayyad RMA, Ousman MS, Hamdan AME, Fahim SA.   +9 more
europepmc   +1 more source

Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation. [PDF]

Oncol Res
Zhuo Z, Zhang D, Lu W, Wu X, Cui Y, Zhang W, Zhang M.   +6 more
europepmc   +1 more source

Correlating NAD(P)H lifetime shifts to tamoxifen resistance in breast cancer cells: A metabolic screening study with time-resolved flow cytometry. [PDF]

J Innov Opt Health Sci
Valentino S, Ortega-Sandoval K, Houston KD, Houston JP.   +3 more
europepmc   +1 more source

MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2. [PDF]

Cell Prolif
Han X, Zhang Y, Li Y, Lin Z, Fu Z, Wang C, Zhang S, Shao D, Li C.   +8 more
europepmc   +1 more source

Targeting LINC00152 activates cAMP/Ca²⁺/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. [PDF]

Cell Death Dis
Saatci O, Alam R, Huynh-Dam KT, Isik A, Uner M, Belder N, Ersan PG, Tokat UM, Ulukan B, Cetin M, Calisir K, Gedik ME, Bal H, Sener Sahin O, Riazalhosseini Y, Thieffry D, Gautheret D, Ogretmen B, Aksoy S, Uner A, Akyol A, Sahin O.   +21 more
europepmc   +1 more source

Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance. [PDF]

Breast Cancer Res
Song T, Zhang H, Zhao Q, Hu Z, Wang Z, Song Y, Zhang Z.   +6 more
europepmc   +1 more source

Cystathionine-γ-lyase contributes to tamoxifen resistance, and the compound I194496 alleviates this effect by inhibiting the PPARγ/ACSL1/STAT3 signalling pathway in oestrogen receptor-positive breast cancer. [PDF]

Sci Rep
Fu H, Han X, Guo W, Zhao X, Yu C, Zhao W, Feng S, Wang J, Zhang Z, Lei K, Li M, Wang T.   +11 more
europepmc   +1 more source